Thursday, February 09, 2006

Vaginal Oestrogen May Stop New Breast Cancer Drugs Working, Say UK Specialists

Medical News Today, January 28, 2006
Breast cancer specialists from one of the UK's leading cancer centres cautioned doctors of the risks in prescribing vaginal oestrogen to breast cancer patients being treated with the new aromatase inhibiting drugs, anastrozole, letrozole and exemestane. Their concerns follow findings from the first study to examine the impact of vaginal oestrogen in women receiving aromatase inhibitors (AIs) for breast cancer, published on-line today in Annals of Oncology, by a team from the Royal Marsden NHS Foundation Trust in London. --Click the title of this post to read the full article from its source--


Post a Comment

<< Home

/* WebRing Code */